2006 | A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma | 성주명 | Article |
2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 문영철 | Article |
2014 | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study | 문영철 | Article |
2014 | Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study | 문영철 | Article |
2009 | Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry | 문영철 | Article |
2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | 문영철 | Article |
2013 | Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes | 성주명; 문영철 | Article |
2010 | Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine | 문영철 | Article |
2015 | Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML | 김형래 | Article |
2014 | Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia | 성주명 | Article |
2013 | Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation | 문영철 | Article |
2006 | Effects of pure curry consumption on life span, body weight, and weight of organs in mice transplanted with cancer cells | 정명수 | Article |
2013 | Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia | 문영철 | Article |
2005 | High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization | 성주명 | Article |
2018 | Identification of Novel Functional Variants of SIN3A and SRSF1 among Somatic Variants in Acute Myeloid Leukemia Patients | 김형래 | Article |
2017 | Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia | 김형래 | Article |
2001 | Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study | 이순남 | Article |
2014 | Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea - Experience from 110 patients | 문영철 | Article |
2010 | Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide | 문영철 | Article |
2013 | Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT | 문영철 | Article |
2003 | Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial | 성주명 | Article |
2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 문영철 | Article |
2020 | Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples | 김형래 | Article |
2012 | Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trial | 성주명 | Article |
2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: A retrospective multicenter study (KMM160) | 문영철 | Article |